Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-19-000054
Filing Date
2019-11-12
Accepted
2019-11-12 16:31:52
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20190930.htm   iXBRL 10-Q 1129980
2 EXHIBIT 31.1 slrx20190930ex-311.htm EX-31.1 9818
3 EXHIBIT 31.2 slrx20190930ex-312.htm EX-31.2 9937
4 EXHIBIT 32.1 slrx20190930ex-321.htm EX-32.1 8627
  Complete submission text file 0001615219-19-000054.txt   5162850

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20190930.xsd EX-101.SCH 35973
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20190930_cal.xml EX-101.CAL 66360
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20190930_def.xml EX-101.DEF 177732
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20190930_lab.xml EX-101.LAB 496043
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20190930_pre.xml EX-101.PRE 317459
28 EXTRACTED XBRL INSTANCE DOCUMENT flks-20190930_htm.xml XML 791194
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 191210024
SIC: 2834 Pharmaceutical Preparations